StocksFin Logo
Danaher Corporation
Danaher Corporation country of incorporation
|
https://www.danaher.com
|
Mr. Thomas Joyce
|
78,000 employees
NYSE | Healthcare | Diagnostics & Research
Novo Nordisk A/S
Novo Nordisk A/S country of incorporation
|
https://www.novonordisk.com
|
Mr. Lars Fruergaard Jrgensen
|
52,696 employees
NYSE | Healthcare | Biotechnology
Q322 reported Oct 20, 2022 Reporting Period
$7.66B 6% vs. Q321 Revenues Q322
59.82% -0.8% vs. Q321 Gross Profit Margin
20.51% 28.1% vs. Q321 Net Profit Margin
1.73B -14.8% vs. Q321 Free Cash Flow Q322
$2.13 36.5% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.41%
Q322
Q322 reported Sep 30, 2022 Reporting Period
$45.57B 27.9% vs. Q321 Revenues Q322
84.2% 1.5% vs. Q321 Gross Profit Margin
31.61% -7.1% vs. Q321 Net Profit Margin
20.01B -6.9% vs. Q321 Free Cash Flow Q322
$6.37 20.4% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
0.41%
Q322
Ratios
As of
Dec 31, 2022
Dec 31, 2022
Quick Ratio
1.3
0.67
Current Ratio
1.89
0.89
Cash Ratio
0.71
0.1
Price to Book
3.95
23.85
Price to Sales
6.29
11.25
Price to Earnings
27.87
35.86